BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4037771)

  • 1. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M; Grégoire S; Caron M; Bergeron MG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.
    Kalager T; Digranes A; Bergan T; Solberg CO
    J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.
    Korting HC; Schäfer-Korting M; Maass L; Klesel N; Mutschler E
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1822-5. PubMed ID: 3435129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole concentrations in human skin blister fluid and plasma.
    Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the extravascular distribution of cefotiam (SCE 963) by the skin blister technic].
    Bryskier A; Elbaz P; Fourtillan JB; Ortonne JP
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):506-8. PubMed ID: 6087248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
    Pollock AA; Tee PE; Patel IH; Spicehandler J; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfer of cefmenoxime to burn blister fluids].
    Nishizaki A; Aoyama H; Koh T; Izawa Y
    Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.
    Korting HC; Schäfer-Korting M; Haag R; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):218-20. PubMed ID: 6325353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
    Korting HC
    Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of tinidazole into skin blister fluid following its oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Eur J Clin Pharmacol; 1992; 43(5):523-6. PubMed ID: 1483489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of ceftriaxone in patients with neoplastic disease.
    Salvador P; Smith RG; Weinfeld RE; Ellis DH; Bodey GP
    Antimicrob Agents Chemother; 1983 Apr; 23(4):583-8. PubMed ID: 6305263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1204-9. PubMed ID: 2393282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.
    Patel IH; Weinfeld RE; Konikoff J; Parsonnet M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):957-62. PubMed ID: 6287931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.